0001209191-23-000300.txt : 20230103
0001209191-23-000300.hdr.sgml : 20230103
20230103170120
ACCESSION NUMBER: 0001209191-23-000300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fuhrman Alan
CENTRAL INDEX KEY: 0001303521
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 23503036
MAIL ADDRESS:
STREET 1: C/O AMBIT BIOSCIENCES CORPORATION
STREET 2: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-01
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001303521
Fuhrman Alan
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
7.60
2023-01-01
4
A
0
32800
0.00
A
2032-12-31
Common Stock
32800
32800
D
Stock Option (Right to Buy)
7.60
2023-01-01
4
A
0
328000
0.00
A
2032-12-31
Common Stock
328000
328000
D
25% of the shares subject to the option shall vest on January 1, 2024, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
The option vests based on achievement of a performance objective.
/s/ Ali D. Fawaz, Attorney-in-Fact
2023-01-03